Search Results - "Cervera, R"

CAPS Registry by Cervera, R

“…Patients with catastrophic antiphospholipid syndrome (APS) have in common: a) clinical evidence of multiple organ involvement developing over a very short…”
Get full text

Catastrophic antiphospholipid syndrome (CAPS): update from the ‘CAPS Registry’ by Cervera, R.

“…Although less than 1% of patients with the antiphospholipid syndrome (APS) develop the catastrophic variant, its potentially lethal outcome emphasizes its…”
Get full text

The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide by Houssiau, F A, Vasconcelos, C, D'Cruz, D, Sebastiani, G D, de Ramon Garrido, E, Danieli, M G, Abramovicz, D, Blockmans, D, Cauli, A, Direskeneli, H, Galeazzi, M, Gül, A, Levy, Y, Petera, P, Popovic, R, Petrovic, R, Sinico, R A, Cattaneo, R, Font, J, Depresseux, G, Cosyns, J-P, Cervera, R

“…To update the follow-up of the Euro-Lupus Nephritis Trial (ELNT), a randomised prospective trial comparing low-dose (LD) and high-dose (HD) intravenous (IV)…”
Get more information

Autoimmune/inflammatory syndrome induced by adjuvants (Shoenfeld’s syndrome) – An update by Watad, A, Quaresma, M, Brown, S, Cohen Tervaert, J W, Rodríguez-Pint, I, Cervera, R, Perricone, C, Shoenfeld, Y

“…Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) has been widely described in many studies conducted thus far. The syndrome incorporates five…”
Get full text

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) by MIYAKIS, S., LOCKSHIN, M. D., ATSUMI, T., BRANCH, D. W., BREY, R. L., CERVERA, R., DERKSEN, R. H. W. M., DE GROOT, P. G., KOIKE, T., MERONI, P. L., REBER, G., SHOENFELD, Y., TINCANI, A., VLACHOYIANNOPOULOS, P. G., KRILIS, S. A.

“…New clinical, laboratory and experimental insights, since the 1999 publication of the Sapporo preliminary classification criteria for antiphospholipid syndrome…”
Get full text

EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics by Bertsias, G, Ioannidis, J P A, Boletis, J, Bombardieri, S, Cervera, R, Dostal, C, Font, J, Gilboe, I M, Houssiau, F, Huizinga, T, Isenberg, D, Kallenberg, C G M, Khamashta, M, Piette, J C, Schneider, M, Smolen, J, Sturfelt, G, Tincani, A, van Vollenhoven, R, Gordon, C, Boumpas, D T

“…Systemic lupus erythematosus (SLE) is a complex disease with variable presentations, course and prognosis. We sought to develop evidence-based recommendations…”
Get more information

EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome by Andreoli, L, Bertsias, G K, Agmon-Levin, N, Brown, S, Cervera, R, Costedoat-Chalumeau, N, Doria, A, Fischer-Betz, R, Forger, F, Moraes-Fontes, M F, Khamashta, M, King, J, Lojacono, A, Marchiori, F, Meroni, P L, Mosca, M, Motta, M, Ostensen, M, Pamfil, C, Raio, L, Schneider, M, Svenungsson, E, Tektonidou, M, Yavuz, S, Boumpas, D, Tincani, A

“…Develop recommendations for women's health issues and family planning in systemic lupus erythematosus (SLE) and/or antiphospholipid syndrome (APS). Systematic…”
Get more information

EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs by Bertsias, G K, Ioannidis, J P A, Aringer, M, Bollen, E, Bombardieri, S, Bruce, I N, Cervera, R, Dalakas, M, Doria, A, Hanly, J G, Huizinga, T W J, Isenberg, D, Kallenberg, C, Piette, J C, Schneider, M, Scolding, N, Smolen, J, Stara, A, Tassiulas, I, Tektonidou, M, Tincani, A, van Buchem, M A, van Vollenhoven, R, Ward, M, Gordon, C, Boumpas, D T

“…To develop recommendations for the diagnosis, prevention and treatment of neuropsychiatric systemic lupus erythematosus (NPSLE) manifestations. The authors…”
Get more information

Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation by Snowden, J A, Saccardi, R, Allez, M, Ardizzone, S, Arnold, R, Cervera, R, Denton, C, Hawkey, C, Labopin, M, Mancardi, G, Martin, R, Moore, J J, Passweg, J, Peters, C, Rabusin, M, Rovira, M, van Laar, J M, Farge, D

“…In 1997, the first consensus guidelines for haematopoietic SCT (HSCT) in autoimmune diseases (ADs) were published, while an international coordinated clinical…”
Get full text

Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients by Cervera, R, Serrano, R, Pons-Estel, G J, Ceberio-Hualde, L, Shoenfeld, Y, de Ramón, E, Buonaiuto, V, Jacobsen, S, Zeher, M M, Tarr, T, Tincani, A, Taglietti, M, Theodossiades, G, Nomikou, E, Galeazzi, M, Bellisai, F, Meroni, P L, Derksen, R H W M, de Groot, P G D, Baleva, M, Mosca, M, Bombardieri, S, Houssiau, F, Gris, J-C, Quéré, I, Hachulla, E, Vasconcelos, C, Fernández-Nebro, A, Haro, M, Amoura, Z, Miyara, M, Tektonidou, M, Espinosa, G, Bertolaccini, M L, Khamashta, M A

“…To assess the prevalence of the main causes of morbi-mortality in the antiphospholipid syndrome (APS) during a 10-year-follow-up period and to compare the…”
Get more information

A phase III, randomized, placebo‐controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus by Furie, Richard, Petri, Michelle, Zamani, Omid, Cervera, Ricard, Wallace, Daniel J., Tegzová, Dana, Sanchez‐Guerrero, Jorge, Schwarting, Andreas, Merrill, Joan T., Chatham, W. Winn, Stohl, William, Ginzler, Ellen M., Hough, Douglas R., Zhong, Z. John, Freimuth, William, van Vollenhoven, Ronald F.

“…Objective To assess the efficacy/safety of the B lymphocyte stimulator inhibitor belimumab plus standard therapy compared with placebo plus standard therapy in…”
Get full text

Treat-to-target in systemic lupus erythematosus: recommendations from an international task force by van Vollenhoven, Ronald F, Mosca, Marta, Bertsias, George, Isenberg, David, Kuhn, Annegret, Lerstrøm, Kirsten, Aringer, Martin, Bootsma, Hendrika, Boumpas, Dimitrios, Bruce, Ian N, Cervera, Ricard, Clarke, Ann, Costedoat-Chalumeau, Nathalie, Czirják, László, Derksen, Ronald, Dörner, Thomas, Gordon, Caroline, Graninger, Winfried, Houssiau, Frédéric, Inanc, Murat, Jacobsen, Søren, Jayne, David, Jedryka-Goral, Anna, Levitsky, Adrian, Levy, Roger, Mariette, Xavier, Morand, Eric, Navarra, Sandra, Neumann, Irmgard, Rahman, Anisur, Rovensky, Jozef, Smolen, Josef, Vasconcelos, Carlos, Voskuyl, Alexandre, Voss, Anne, Zakharova, Helena, Zoma, Asad, Schneider, Matthias

“…The principle of treating-to-target has been successfully applied to many diseases outside rheumatology and more recently to rheumatoid arthritis. Identifying…”
Get more information

McMaster RARE‐Bestpractices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome by Legault, K., Schunemann, H., Hillis, C., Yeung, C., Akl, E. A., Carrier, M., Cervera, R., Crowther, M., Dentali, F., Erkan, D., Espinosa, G., Khamashta, M., Meerpohl, J. J., Moffat, K., O'Brien, S., Pengo, V., Rand, J. H., Rodriguez Pinto, I., Thom, L., Iorio, A.

“…Summary Background The McMaster RARE‐Bestpractices project group selected the catastrophic antiphospholipid syndrome (CAPS) for a pilot exercise in guideline…”
Get full text

‘ASIA’: a new systemic autoimmune syndrome? by Cervera, R

Get full text

Catastrophic antiphospholipid syndrome: task force report summary by Cervera, R, Rodríguez-Pintó, I

“…The Task Force on Catastrophic Antiphospholipid Syndrome (CAPS) aimed to assess the current knowledge on pathogenesis, clinical and laboratory features,…”
Get full text

Causes and factors related to hospitalizations in patients with systemic lupus erythematosus: analysis of a 20-year period (1995–2015) from a single referral centre in Catalonia by Rosa, G Pires da, Ortega, M Fontecha, Teixeira, A, Espinosa, G, Cervera, R

“…Introduction Although extensively characterized in the outpatient setting, systemic lupus erythematosus (SLE) in the hospitalization wards is still scarcely…”
Get full text

Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response by van Vollenhoven, Ronald F, Petri, Michelle A, Cervera, Ricard, Roth, David A, Ji, Beulah N, Kleoudis, Christi S, Zhong, Z John, Freimuth, William

“…To identify factors that predict response to belimumab treatment in the phase 3 BLISS trials of autoantibody-positive systemic lupus erythematosus (SLE) and…”
Get more information

EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases by van Assen, S, Agmon-Levin, N, Elkayam, O, Cervera, R, Doran, M F, Dougados, M, Emery, P, Geborek, P, Ioannidis, J P A, Jayne, D R W, Kallenberg, C G M, Müller-Ladner, U, Shoenfeld, Y, Stojanovich, L, Valesini, G, Wulffraat, N M, Bijl, M

“…To develop evidence-based European League Against Rheumatism (EULAR) recommendations for vaccination in patients with autoimmune inflammatory rheumatic…”
Get more information

Performance of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in early disease, across sexes and ethnicities by Johnson, Sindhu R, Brinks, Ralph, Costenbader, Karen H, Daikh, David, Mosca, Marta, Ramsey-Goldman, Rosalind, Smolen, Josef S, Wofsy, David, Boumpas, Dimitrios T, Kamen, Diane L, Jayne, David, Cervera, R, Costedoat-Chalumeau, Nathalie, Diamond, Betty, Gladman, Dafna D, Hahn, Bevra, Hiepe, Falk, Jacobsen, Søren, Khanna, Dinesh, Lerstrøm, Kirsten, Massarotti, Elena, McCune, Joseph, Ruiz-Irastorza, Guillermo, Sanchez-Guerrero, Jorge, Schneider, Matthias, Urowitz, Murray, Bertsias, George, Hoyer, Bimba F, Leuchten, Nicolai, Tani, Chiara, Tedeschi, Sara K, Touma, Zahi, Schmajuk, Gabriela, Anic, Branimir, Assan, Florence, Chan, Tak Mao, Clarke, Ann Elaine, Crow, Mary K, Czirják, László, Doria, Andrea, Graninger, Winfried B, Halda-Kiss, Bernadett, Hasni, Sarfaraz, Izmirly, Peter M, Jung, Michelle, Kumánovics, Gábor, Mariette, Xavier, Padjen, Ivan, Pego-Reigosa, José M, Romero-Diaz, Juanita, Rúa-Figueroa, Íñigo, Seror, Raphaèle, Stummvoll, Georg H, Tanaka, Yoshiya, Tektonidou, Maria G, Vasconcelos, Carlos, Vital, Edward M, Wallace, D J, Yavuz, Sule, Meroni, Pier Luigi, Fritzler, Marvin J, Naden, Ray, Dörner, Thomas, Aringer, Martin

“…The European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) 2019 Classification Criteria for systemic lupus erythematosus (SLE) have…”
Get more information

European Forum On Antiphospholipid Antibodies: brief history report and governance document by Cervera, R

“…The European Forum on Antiphospholipid Antibodies was conceived as a multidisciplinary network of different specialists working in the fields of internal…”
Get full text